Latest / Stock Movers / Nvidia Set to Report; Take-Two Jumps; Crypto Slide
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios, podcasts, radio, news. The Stock Movers Report,
- 0:10Speaker 1: your roundup of companies making moves in the stock market,
- 0:13Speaker 1: harnessing the power of Bloomberg data.
- 0:15Speaker 2: Let's take a look at some stocks on the move today.
- 0:18Speaker 2: I'm Nathan Hager, joined by Bloomberg's Chloe Mellie, starting us
- 0:22Speaker 2: off with NVIDIA, of course, because So much has been
- 0:25Speaker 2: happening with this company, even after the ouster of Jensen Wong.
- 0:29Speaker 1: Good morning, Chloe. Good morning, Nathan.
- 0:31Speaker 3: Yes, it's a new week and NVIDIA is still very
- 0:34Speaker 3: much in focus. Shares are still under pressure in pre-market
- 0:38Speaker 3: trading this morning after the big tumble that they took
- 0:42Speaker 3: last week. So the focus this week is going to
- 0:45Speaker 3: be on the earnings, of course, tomorrow, where the interim
- 0:48Speaker 3: CEO is going to be facing a lot of questions.
- 0:51Speaker 3: And then the next big challenge is probably going to
- 0:54Speaker 3: be increasing government scrutiny. You know, we had Treasury Secretary
- 0:58Speaker 3: Scott Besant urging NVIDIA to make a dramatic leadership shakeup,
- 1:03Speaker 3: which would mean probably finding an external candidate for the
- 1:07Speaker 3: CEO role, and also urging NVIDIA to come clean about
- 1:11Speaker 3: its compliance with export controls to China and whether or
- 1:15Speaker 3: not it adds appropriate security protocols around all of this. So,
- 1:19Speaker 3: It's guaranteed to be another week that's very much all
- 1:21Speaker 3: about NVIDIA.
- 1:23Speaker 2: And all about possibly Take-Two Interactive as well. How's that
- 1:27Speaker 2: stock doing before all the traders take the day off
- 1:30Speaker 2: for the GTA 6 release?
- 1:32Speaker 3: Yeah, it's guaranteed to be a better week for Take-Two
- 1:36Speaker 3: than for Nvidia with the launch, as you said, of
- 1:38Speaker 3: GTA 6 on Thursday. That is looking like it's going
- 1:41Speaker 3: to be a success, quite a big success. We had
- 1:45Speaker 3: Jefferies analysts saying that pre-orders are tracking above expectations, which
- 1:49Speaker 3: would mean probably a very strong 2027. for take two
- 1:53Speaker 3: with sales likely coming in above estimates and probably a
- 1:57Speaker 3: strong 2028 as well given that there would be a
- 2:00Speaker 3: pc release at some point that would kind of boost
- 2:03Speaker 3: those bookings even further i've never played gta myself but
- 2:06Speaker 3: everyone's excited so i'm happy for them I got to.
- 2:10Speaker 2: Admit, I haven't played it either, but you're right. It
- 2:12Speaker 2: does seem like everybody is just gangbusters for this game.
- 2:16Speaker 2: We got to talk about crypto exposed stocks as well
- 2:20Speaker 2: with Bitcoin trading below 65K this morning.
- 2:24Speaker 3: Yeah, we have a downward spiral for Bitcoin and that
- 2:27Speaker 3: is dragging down all of those crypto exposed stocks. So
- 2:30Speaker 3: we are seeing a Galaxy Digital, Circle Internet, Coinbase, all
- 2:34Speaker 3: of those names very much in the red this morning.
- 2:37Speaker 3: There's a few challenges facing that crypto industry that is
- 2:41Speaker 3: now translating into investors really increasingly turning away. There was
- 2:46Speaker 3: the massive hack at Binance that was seen as a
- 2:49Speaker 3: major security crisis for that sector. There's, of course, all
- 2:52Speaker 3: that political uncertainty that is very much dominating since the midterms.
- 2:57Speaker 3: There's rising treasury yields, a stronger dollar, all of that
- 3:00Speaker 3: resulting in that weakness that's really dragging Those stocks and
- 3:04Speaker 3: traders are bracing for even more losses.
- 3:07Speaker 2: Just time to tell us about the biggest decliner in
- 3:10Speaker 2: the pre-market this morning. That's Summit Therapeutics.
- 3:13Speaker 3: Yes, so Summit Therapeutics and its partner, Acasa, which is
- 3:16Speaker 3: a Chinese biotech company, both of those are plunging after
- 3:20Speaker 3: the FDA rejected Acasa. the lung cancer treatment that they
- 3:24Speaker 3: are developing. You know, while the treatment actually stopped the
- 3:27Speaker 3: cancer from worsening, that alone wasn't actually sufficient to warrant
- 3:32Speaker 3: FDA approval. So that's, of course, a major setback for
- 3:35Speaker 3: both those companies and with huge drops for those stocks.
- 3:39Speaker 1: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:43Speaker 1: us throughout the day for the latest roundup of companies
- 3:46Speaker 1: making news on Wall Street. And for the latest market-moving headlines,
- 3:50Speaker 1: listen to Bloomberg Radio Live. Catch us on YouTube, Bloomberg.com,
- 3:55Speaker 1: and on Apple CarPlay and Android Auto with the Bloomberg
- 3:58Speaker 1: Business app.